The diagnostic role of Procalcitonin and other biomarkers in discriminating infectious from non-infectious fever

被引:250
作者
Limper, M. [1 ,2 ]
de Kruif, M. D. [1 ]
Duits, A. J. [2 ]
Brandjes, D. P. M. [1 ]
van Gorp, E. C. M. [1 ,3 ]
机构
[1] Slotervaart Hosp, Dept Internal Med, NL-1066 EC Amsterdam, Netherlands
[2] Red Cross Blood Bank Fdn, Immunol Lab Dept, Willemstad, Curacao, Neth Antilles
[3] Erasmus MC, Dept Virol, Rotterdam, Netherlands
关键词
Fever; Biological markers; Autoimmune diseases; C-reactive protein; Procalcitonin; C-REACTIVE PROTEIN; FAMILIAL-MEDITERRANEAN-FEVER; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE MYOCARDIAL-INFARCTION; INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; ACUTE-PHASE RESPONSE; SERUM PROCALCITONIN; BACTERIAL-INFECTION; PULMONARY-EMBOLISM;
D O I
10.1016/j.jinf.2010.03.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Fever is not only observed in the course of a bacterial or viral infection, but can be a symptom of, for instance, auto-immune, malignant or thromboembolic disease. Determining the etiology of fever in a fast and reliable way is of pivotal importance, as different causes of fever may ask for different therapies. Neither clinical signs and symptoms, nor traditional biomarkers, such as CRP, leukocytes and ESR have sufficient sensitivity and specificity to guide treatment decisions. In this review we focus on the value of traditional and newer biomarkers in non-infectious febrile diseases. Procalcitonin (PCT) seems to be the most helpful laboratory marker for the differentiation of causes of fever, particularly in autoimmune, autoinflammatory and malignant diseases. (C) 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 70 条
  • [61] Interleukin-6
    Song, MC
    Kellum, JA
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : S463 - S465
  • [62] Fever in acute pulmonary embolism
    Stein, PD
    Afzal, A
    Henry, JW
    Villareal, CG
    [J]. CHEST, 2000, 117 (01) : 39 - 42
  • [63] Südhoff T, 2000, ANTIBIOT CHEMOTHER, V50, P10
  • [64] Interleukin-6 secreting phaeochromocytoma associated with clinical markers of inflammation
    Takagi, M
    Egawa, T
    Motomura, T
    SakumaMochizuki, J
    Nishimoto, N
    Kasayama, S
    Hayashi, S
    Koga, M
    Yoshizaki, K
    Yoshioka, T
    Okuyama, A
    Kishimoto, T
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 46 (04) : 507 - 509
  • [65] Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis
    Uzzan, Bernard
    Cohen, Regis
    Nicolas, Patrick
    Cucherat, Michel
    Perret, Gerard-Yves
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (07) : 1996 - 2003
  • [66] Procalcitonin as an early marker of infection in neonates and children
    van Rossum, AMC
    Wulkan, RW
    Oudesluys-Murphy, AM
    [J]. LANCET INFECTIOUS DISEASES, 2004, 4 (10) : 620 - 630
  • [67] Tumour necrosis factor and Crohn's disease
    VanDeventer, SJH
    [J]. GUT, 1997, 40 (04) : 443 - 448
  • [68] Oratory markers in IBD: Magic, or unneccessary toys?
    Vermeire, S
    Van Assche, G
    Rutgeerts, P
    [J]. GUT, 2006, 55 (03) : 426 - 431
  • [69] Proinflammatory Role of Vascular Endothelial Growth Factor in the Pathogenesis of Rheumatoid Arthritis: Prospects for Therapeutic Intervention
    Yoo, Seung-Ah
    Kwok, Seung-Ki
    Kim, Wan-Uk
    [J]. MEDIATORS OF INFLAMMATION, 2008, 2008
  • [70] Neoplastic fever: a neglected paraneoplastic syndrome
    Zell, JA
    Chang, JC
    [J]. SUPPORTIVE CARE IN CANCER, 2005, 13 (11) : 870 - 877